A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension - Full Text View

A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

This study has been completed.

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00372931

Purpose

The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: AL-37807	Phase II

Genetics Home Reference related topics:

early-onset glaucoma

MedlinePlus related topics:

Glaucoma High Blood Pressure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Official Title:	A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

Further study details as provided by Alcon Research:

Primary Outcome Measures:

Estimated Enrollment:	120
Study Start Date:	May 2006
Estimated Study Completion Date:	October 2006
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)

Eligibility

Criteria

Inclusion Criteria:

Adult patients of either sex and any race with open-angle glaucoma or ocular hypertension; logMAR visual acuity not worse than 0.60; additionally clinically relevant ophthalmic or systemic conditions may be excluded

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00372931

Locations


United States, Texas
	San Antonio Site
	San Antonio, Texas, United States, 78240

Sponsors and Collaborators

Alcon Research

Investigators


Study Director:	Theresa Landry	Study Director

More Information

Study ID Numbers:	C-06-15
First Received:	September 6, 2006
Last Updated:	April 21, 2008
ClinicalTrials.gov Identifier:	NCT00372931
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Glaucoma

Eye Diseases

Glaucoma, Open-Angle

Vascular Diseases

Hypertension

Ocular Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 16, 2008